Enrolling Clinical Research Studies
HEALTHY PATIENTS
UPCOMING STUDIES FOR HEALTHY MEN AND WOMEN
Click to add your name to the waiting list for upcoming healthy studies. We will alert you when we begin a new healthy study. Please provide your email address if possible.
*PLEASE DO NOT CALL THE STUDY CENTER UNLESS YOU ARE CONTACTED FIRST*
PSYCHIATRY
IS DEPRESSION ISOLATING YOU FROM LIFE?
If your depression is deep enough to isolate you from life, there is hope. One out of every three patients who have tried several antidepressant treatments still have symptoms of depression. This is known as treatment-resistant depression.
VNS (Vagus Nerve Stimulation) Therapy is a well- studied treatment that is already approved by the FDA for people with treatment-resistant depression. Despite this, Medicare and other insurers do not routinely cover it.
The RECOVER study was designed in partnership with many of the nation’s top experts in treatment-resistant depression, and approved by Medicare, to provide additional evidence of the benefit of VNS Therapy. If the results confirm previous studies, Medicare and other insurers may start to cover it.
Right now, we are actively enrolling patients to participate in the RECOVER study. People who participate in RECOVER will receive VNS Therapy and all study-related care at no cost to them.
To join the RECOVER study, you must be 18 years or older and:
- Currently depressed
- Have depression, or bipolar depression, that has lasted for at least two years or recurred several times
- Have tried at least four types of antidepressant treatments and not found them helpful
Take the next step
To see if you might qualify for the RECOVER study, please click Study Details and fill out the brief questionnaire
PSYCHIATRY
Is Bipolar I depression affecting your child or teen?
The Balance Study Bipolar I depression can change the way a child or teen interacts with the world around them.
If you or your child have bipolar I depression, we are inviting you to take part in the Balance Study for children and adolescents, aged 10 to 17 years of age, who have been struggling with bipolar I depression. The purpose of this study is to evaluate the safety and efficacy of an investigational drug for bipolar I depression in children and adolescents. The Balance Study will enroll about 380 children and adolescents with bipolar I depression at participating study centers throughout North America. After completing 8 visits in the Balance Study, you may be able to participate in an open-label study.
Who can take part in the Balance Study?
You or your child may be eligible to join the Balance study if you or they:
• Are 10 to 17 years old
• Have a diagnosis of bipolar I disorder
• Are currently experiencing an episode of depression:
  – Symptoms of depression include feeling sad, down, or depressed, not enjoying  things you usually do, suicidal thoughts, difficulty falling or staying asleep, loss of energy, difficulty concentrating
There is no cost to participate in the study. Patients who take part will receive all study-related visits, tests, and investigational drug from a dedicated medical team at no cost. No health insurance is required.
PSYCHIATRY
Eploring routes away from treatment-resistant depression
Introducing the COMP 005 Study
Learn more about a study looking at a new investigational treatment approach
for treatment-resistant depression using an investigational medicine alongside
psychological support.
You may be able to join the study if you:Â
- Are 18 years of age or older
- Have been diagnosed with depression and have not responded to anti depressants
Other criteria will need to be met to confirm your eligibility for this study, which will last up to 62 weeks.
Study participants receive investigational treatment and follow-up care at no cost. Travel and study-related costs may be reimbursed. You can find out more by talking to your local study center or visiting
www.compasspathfinderstudies.com.
Contact us to find out more:
Rivus Wellness & Research Institute
2301 W. I-44 Service Rd., Suite 300 – OKC, OK
Research 405-753-4994 or
Text Melissa at 405-517-4201
PSYCHIATRY
Are you diagnosed with major depressive disorder?
Depression can feel like it never ends.
Learn more about a research study of an investigational drug for adults who have been diagnosed with major depressive disorder (MDD) and who have used an antidepressant medication without sufficient improvement in their depression symptoms.
For more information, please contact:
Rivus Wellness & Research Institute
2301 W. I-44 Service Rd., Suite 300 – OKC, OK 73112
clinic 405-607-2233 research 405-753-4994
PSYCHIATRY
IS YOUR LIFE DISRUPTED BY FREQUENT PANIC ATTACKS?
If so, you may be interested in this opportunity to join a research study of a new investigational drug for panic disorder.
Please contact us to learn more about participating in this research study if you meet the following conditions:
- are 18 to 65 years of age
- have had panic disorder for at least 6 months
- have had 8 or more panic attacks in the last month with no weeks free of panic attacks
There is no charge for study participation and compensation is available to those who satisfy applicable requirements.
Please contact us today to learn if you may be able to participate.
Rivus Wellness & Research Institute
2301 W. I-44 Service Road, Suite 300
OKC, OK 73112
clinic 405-607-2233
research 405-753-4994
PSYCHIATRY
Still Struggling with Opioid Use Disorder?
The clinical research study is looking for participants diagnosed with moderate to severe opioid use disorder (OUD). If you have been struggling with moderate to severe OUD, you may qualify for our clinical research study.
This study aims to evaluate the effectiveness of an investigational medication for adults 18 to 65 who are interested in switching to a non opioid treatment option for their OUD.
You may qualify for the study if you:
- Are 18 – 65 years of age
- Have been diagnosed with moderate to severe opioid use disorder
- Meet additional study criteria
Ask your doctor if the OUD Study may be right for you or visit OUDStudy.com for more information. If you qualify, reimbursement for reasonable, out of-pocket expenses for travel and accommodations may be available.
Rivus Wellness and Research Institute
2301 West I-44 Service Rd, Suite 300
Oklahoma City, OK 73112
405-753-4994
CLINICAL RESEARCH PARTNERS
Get in touch
Have a question or need assistance? We are here to help. Whether you're curious about our clinic, research programs, or simply want to connect with us, don't hesitate to reach out.
- 2301 WEST I-44 SERVICE ROAD, SUITE 300, OKLAHOMA CITY, OK 73112
- 405 607 2233
- 405 286 8693
PSYCHIATRY
IS DEPRESSION ISOLATING YOU FROM LIFE?
If your depression is deep enough to isolate you from life, there is hope. One out of every three patients who have tried several antidepressant treatments still have symptoms of depression. This is known as treatment-resistant depression.
VNS (Vagus Nerve Stimulation) Therapy is a well- studied treatment that is already approved by the FDA for people with treatment-resistant depression. Despite this, Medicare and other insurers do not routinely cover it.
The RECOVER study was designed in partnership with many of the nation’s top experts in treatment-resistant depression, and approved by Medicare, to provide additional evidence of the benefit of VNS Therapy. If the results confirm previous studies, Medicare and other insurers may start to cover it.
Right now, we are actively enrolling patients to participate in the RECOVER study. People who participate in RECOVER will receive VNS Therapy and all study-related care at no cost to them.
To join the RECOVER study, you must be 18 years or older and:
- Currently depressed
- Have depression, or bipolar depression, that has lasted for at least two years or recurred several times
- Have tried at least four types of antidepressant treatments and not found them helpful
Take the next step
To see if you might qualify for the RECOVER study, please click Study Details and fill out the brief questionnaire